Patent ductus arteriosus: lack of evidence for common treatments

AUTOR(ES)

Bose, Carl L

FONTE

BMJ Group

RESUMO

Patent ductus arteriosus (PDA) is a common diagnosis among extremely premature infants, especially in those with lung disease. Treatments are often used to close the PDA. Despite nearly three decades of research, the question of whether the benefits of treatments to prevent ductal patency or promote closure outweigh the risks of these treatments remains unanswered. The authors rarely use treatments designed to close the PDA. This article reviews three considerations in support of this restrained approach: rates of spontaneous closure of the ductus arteriosus; adverse effect of persistent ductal patency; and benefits and risks of treatments for closure.

Documentos Relacionados

• Extrapleural Closure of Patent Ductus Arteriosus: How We Do It
• Towards rational management of the patent ductus arteriosus: the need for disease staging
• Syndromic patent ductus arteriosus: Evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder
• Surgery of isolated patent ductus arteriosus: a new technique of suture and division.
• Primary bronchomalacia and patent ductus arteriosus: simultaneous surgical correction in an infant.